| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ARRAY BIOPHARMA INC COM | 9,405,817 | 69,321,000 | 14.50% | ||
| 2 | CHEMOCENTRYX INC | 8,303,084 | 62,688,000 | 13.11% | ||
| 3 | IRONWOOD PHARMACEUTICALS INC COM CL A | 2,171,108 | 34,738,000 | 7.26% | ||
| 4 | FORWARD PHARMA A/S | 1,177,481 | 33,346,000 | 6.97% | ||
| 5 | ONCOMED PHARMACEUTICALS INC | 1,284,115 | 33,104,000 | 6.92% | ||
| 6 | Exelexis | 31,239,000 | 23,937,000 | 5.01% | PRN | |
| 7 | ONCOTHYREON INC COM N/C EFF 6/ | 14,314,178 | 23,332,000 | 4.88% | ||
| 8 | LIGAND PHARMACEUTICALS INC | 267,090 | 20,595,000 | 4.31% | ||
| 9 | CONCERT PHARMACEUTICALS INC COM | 1,340,659 | 20,304,000 | 4.25% | ||
| 10 | TARGACEPT INC | 6,655,128 | 19,766,000 | 4.13% | ||
| 11 | VITAE PHARMACEUTICALS INC | 1,577,435 | 18,472,000 | 3.86% | ||
| 12 | QLT INC | 4,149,862 | 16,226,000 | 3.39% | ||
| 13 | CYTOKINETICS INC | 2,106,989 | 14,285,000 | 2.99% | ||
| 14 | LOXO ONCOLOGY INC COM | 1,125,665 | 14,015,000 | 2.93% | ||
| 15 | ArQule Inc | 6,174,561 | 13,831,000 | 2.89% | ||
| 16 | EXELIXIS INC | 4,988,357 | 12,820,000 | 2.68% | ||
| 17 | FIVE PRIME THERAPEUTICS INC | 502,832 | 11,490,000 | 2.40% | ||
| 18 | GTX INC | 11,111,111 | 7,508,000 | 1.57% | ||
| 19 | XENON PHARMACEUTICALS INC | 391,424 | 6,601,000 | 1.38% | ||
| 20 | Sunesis Pharmaceuticals I | 1,893,030 | 4,638,000 | 0.97% | ||
| 21 | MAST THERAPEUTICS | 7,241,600 | 3,512,000 | 0.73% | ||
| 22 | BIOLINERX LTD | 1,501,000 | 3,167,000 | 0.66% | ||
| 23 | OncoGenex Pharmaceuticals Inc | 1,368,500 | 2,942,000 | 0.62% | ||
| 24 | REGADO BIOSCIENCES INC | 1,882,521 | 2,297,000 | 0.48% | ||
| 25 | ACHAOGEN INC COM | 136,600 | 1,333,000 | 0.28% | ||
| 26 | MEI PHARMA INC | 600,000 | 1,074,000 | 0.22% | ||
| 27 | Aptose Biosciences Inc Com New | 166,664 | 907,000 | 0.19% | ||
| 28 | BIOTA PHARMACEUTIALS INC COM | 350,776 | 807,000 | 0.17% | ||
| 29 | SOPHIRIS BIO INC | 1,060,283 | 614,000 | 0.13% | ||
| 30 | KALOBIOS PHARMACEUTICALS INC | 1,162,000 | 569,000 | 0.12% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000921895-15-001376, filed 2015.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
